Harris Ann, Harris Henry, Hollingsworth Michael A
Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
Mol Cancer Res. 2007 Dec;5(12):1241-5. doi: 10.1158/1541-7786.MCR-07-0200.
Suppression of tumorigenicity was first shown in hybrids produced by the fusion of a range of different highly malignant tumor cells with diploid fibroblasts. Cytogenetic analysis of these hybrids revealed that suppression involved a genetic region located in one specific chromosome donated to the hybrid cell by the fibroblast parent. The identity of the gene responsible for this dramatic effect has remained obscure. We now present strong evidence that the primary determinant is the gene specifying collagen XV, a proteoglycan closely associated with the basement membrane. We transfected a line of highly tumorigenic human cervical carcinoma cells with an expression vector carrying the full-length cDNA of the human collagen XV gene. We selected clones making various amounts of collagen XV, examined their growth in vitro, and tested their tumorigenicity in nude mice. High levels of collagen XV altered the growth properties of the cells in three-dimensional cultures. Moreover, we found that, in a dose-dependent manner, the production of collagen XV completely suppressed tumorigenicity in clones that synthesized this molecule at high levels. Immunohistologic studies suggest that suppression is associated with extracellular deposition of the proteoglycan at the cell periphery.
肿瘤致瘤性的抑制最早在一系列不同的高恶性肿瘤细胞与二倍体成纤维细胞融合产生的杂交细胞中得到证实。对这些杂交细胞的细胞遗传学分析表明,抑制作用涉及一个位于成纤维细胞亲本捐赠给杂交细胞的一条特定染色体上的遗传区域。负责这种显著效应的基因的身份一直不明。我们现在提供了有力证据,表明主要决定因素是指定胶原蛋白XV的基因,胶原蛋白XV是一种与基底膜密切相关的蛋白聚糖。我们用携带人胶原蛋白XV基因全长cDNA的表达载体转染了一株高致瘤性的人宫颈癌细胞系。我们筛选出产生不同量胶原蛋白XV的克隆,检测它们在体外的生长情况,并在裸鼠中测试它们的致瘤性。高水平的胶原蛋白XV改变了细胞在三维培养中的生长特性。此外,我们发现,胶原蛋白XV的产生以剂量依赖的方式完全抑制了在高水平合成该分子的克隆中的致瘤性。免疫组织学研究表明,抑制作用与蛋白聚糖在细胞周边的细胞外沉积有关。